O cenário
A pharmaceutical company faces repeated delays in filing new drug applications, risking market access and compliance. This analysis maps out potential root causes across multiple domains.
O que há neste desenho
Entenda as decisões por trás dele.
01
Prioritize process and system improvements
02
Enhance training programs
03
Implement real-time tracking dashboards
When diagnosing delays in regulatory submissions, especially for eCTD-based filings, and aiming to identify systemic issues.